| Code | 8616D | ||||||||||
| MA number | 44/0247/21-S | ||||||||||
| Product Form: | tbl flm 14x250 mg (blis.Al/PVC/PE/PVDC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.10.2021 |
| Validity: | 22.10.2026 |
| SPC: |
SPC_Abiraterón STADA 250 mg filmom obalené tablety_10.2024.pdf
|
| PIL: |
PIL_Abiraterón STADA 250 mg filmom obalené tablety_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 10.06.2022 |
